Imatinib in Dermatofibrosarcoma Protuberans (DFSP)

NCT00122473 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

30

Enrollment

OTHER

Sponsor class

Conditions

Dermatofibrosarcoma

Interventions

DRUG: Imatinib (Glivec)

Sponsor

Dermatologic Cooperative Oncology Group